Smaller 7 French Compatible Atherectomy Catheter Now Available to Treat Larger Patient Population KIRKLAND, Wash., Aug 10–(HSMN NewsFeed)–Pathway Pharmaceutical Technologies, Inc., an innovator of endovascular treatments for peripheral arterial disease (PAD)…
Devices, Interventional
Pathway Medical Technologies, Jetstream G2 NXT, PAD , Jetstream
Posts on ‘August 10th, 2009’
Pathway Pharma Technologies Introduces Jetstream G2 NXT
The Medicines Company Responds to Incorrect News Reports
PARSIPPANY, NJ–(HSMN NewsFeed) - The Medicines Company (NASDAQ:MDCO ) announced today that it had responded to inaccurate implications in a column in The New York Times on August 9, 2009 by Frank Rich and a report that aired on Rachel Maddow’s news show o…
Biopharmaceuticals, Cardiology
The Medicines Company
APP Pharmaceuticals Receives Approval for Idarubicin HCI Injection
SCHAUMBURG, Ill., Aug 10–(HSMN NewsFeed)–APP Pharmaceuticals, Inc., a wholly owned subsidiary of Fresenius Kabi Pharmaceuticals Holding, Inc. (NASDAQ:APCVZ ), announced today that it has received approval from the U.S. Food and Drug Administration (FDA) …
Biopharmaceuticals, Generics, FDA
APP Pharmaceuticals, idarubicin, Idamycin, Pfizer
Rexahn Promotes Rick Soni to President and Chief Operating Officer
ROCKVILLE, Md.–(HSMN NewsFeed)–Rexahn Pharmaceuticals, Inc. (NYSE Amex: RNN), a clinical stage clinical company commercializing potential best in class oncology and CNS therapeutics, today announced the promotion of Mr. Rick Soni to President and C…
Biopharmaceuticals, Personnel
Rexahn Pharmaceuticals

If you are a sales professional or want to become one, or if you are looking for a new sales job, you will face one of the toughest interview processes of any job seeker.